Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP160100633
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Enhanced multivalent vaccine responses using a novel vaccine vector system. Enhanced multivalent vaccine responses using a novel vaccine vector system. This project aims to develop a multicomponent vaccine system to deliver equal effectiveness against several disease targets in a single administration. New and innovative vaccine design strategies incorporating economical commercial production processes are urgently needed for new and existing human and animal health applications. A vaccine capable of targeting multiple diseases by a single injection is an obvious way to expedite future vaccine development and deployment. However, the recipient’s immune system can repress equivalent responses to these multicomponent vaccines. This project’s research is expected to address these problems, and underpin the future commercial development of this vaccine platform.Funded Activity Details
Start Date: 08-2016
End Date: 08-2019
Funding Scheme: Linkage Projects
Funding Amount: $362,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) | Medical Molecular Engineering of Nucleic Acids and Proteins | Immunology
ANZSRC Socio-Economic Objective (SEO)
Human Biological Preventatives (e.g. Vaccines) | Veterinary Biological Preventatives (e.g. Vaccines) |
